Getting a vaccine to market comes through extensive research, clinical trials and regulatory review as part of a process that takes 10 to 12 years on average. (Photo: Gorodenkoff Productions OU/Adobe Stock)
The COVID-19 vaccine rollout in Canada has rapidly gathered pace after a relatively slow start, with both the number of doses administered per capita and those who are fully vaccinated now exceeding the United States. With 70.7% of the country's population now fully vaccinated, how has the pandemic changed the risk landscape for the life sciences industry?
Want to continue reading?
Become a Free PropertyCasualty360 Digital Reader
Your access to unlimited PropertyCasualty360 content isn’t changing.
Once you are an ALM digital member, you’ll receive:
- All PropertyCasualty360.com news coverage, best practices, and in-depth analysis.
- Educational webcasts, resources from industry leaders, and informative newsletters.
- Other award-winning websites including BenefitsPRO.com and ThinkAdvisor.com.
Already have an account? Sign In
© 2024 ALM Global, LLC, All Rights Reserved. Request academic re-use from www.copyright.com. All other uses, submit a request to [email protected]. For more information visit Asset & Logo Licensing.
